CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer

Clinical trial NCT05081492 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05081492
Sponsor: City of Hope Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Anatomic Stage IV Breast Cancer AJCC v8 Metastatic Triple-Negative Breast Carcinoma Prognostic Stage IV Breast Cancer AJCC v8

Start date: 2021-10-18
Primary completion: 2027-03-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.